Table of Contents

HK J Paediatr (New Series)
Vol 17. No. 4, 2012

HK J Paediatr (New Series) 2012;17:208-216

Original Article

An Update on the Indications of Growth Hor mone Treatment under Hospital Authority in Hong Kong

WM But, KF Huen, CY Lee, YY Lam, WY Tse, CM Yu, on behalf of the Hong Kong Society of Paediatric Endocrinology and Metabolism


Since 1978, Growth hormone (GH) has been used to treat patients with GH deficiency in Hong Kong. In 1998, the Hospital Authority expanded the use of GH in children with Turner syndrome and chronic renal failure before transplantation. Two additional indications for GH treatment, Prader-Willi syndrome and short stature homeobox-containing gene disorders have been approved in 2012. The objective of this paper is to discuss the recommendations of GH treatment for children and adolescents with these conditions in Hong Kong.

Keyword : Growth hormone treatment; Hospital Authority

Abstract in Chinese


This web site is sponsored by Johnson & Johnson (HK) Ltd.
©2024 Hong Kong Journal of Paediatrics. All rights reserved. Developed and maintained by Medcom Ltd.